[HTML][HTML] Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients?
M Walczak, L Lykowska-Szuber, M Plucinska… - Frontiers in …, 2020 - frontiersin.org
Anti-tumor necrosis factor (TNF) therapy is used for the induction and maintenance of
remission in Crohn's disease (CD) patients. However, primary nonresponders to initial …
remission in Crohn's disease (CD) patients. However, primary nonresponders to initial …
Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients?
M Walczak, L Lykowska-Szuber… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Anti-tumor necrosis factor (TNF) therapy is used for the induction and maintenance of
remission in Crohn's disease (CD) patients. However, primary nonresponders to initial …
remission in Crohn's disease (CD) patients. However, primary nonresponders to initial …
[HTML][HTML] Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients?
M Walczak, L Lykowska-Szuber… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Anti-tumor necrosis factor (TNF) therapy is used for the induction and maintenance of
remission in Crohn's disease (CD) patients. However, primary nonresponders to initial …
remission in Crohn's disease (CD) patients. However, primary nonresponders to initial …
Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients?
M Walczak, L Lykowska-Szuber… - Frontiers in …, 2020 - europepmc.org
Anti-tumor necrosis factor (TNF) therapy is used for the induction and maintenance of
remission in Crohn's disease (CD) patients. However, primary nonresponders to initial …
remission in Crohn's disease (CD) patients. However, primary nonresponders to initial …